•  
  •  
  •  
  •  

2026-07-22 05:20:01

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore

Keywords Selected:  EUGMP

Stock Report

  • Indoco's formulation plant at Baddi - Plant III receives EU GMP certification
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • OneSource Specialty Pharma Ltd receives EU GMP Certificate for Sterile Product Division
  • OneSource Specialty Pharma Ltd receives renewal of EU-GMP certification for Unit 2
  • Innoxel Lifesciences Successfully Completes EU GMP Inspection by Belgium's FAMHP
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Indoco receives Certificate of EU GMP Compliance from the European Health Authorities for its sterile drug product manufacturing facility, Goa Plant II
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • SMS Pharma receives EDQM Certification to supply to Ibuprofen in Europe
  • Fermenta Biotech Ltd's API manufacturing facility receives certificate of EU GMP compliance
  • Medicamen Biotech Ltd's facility at Bhiwadi receives final EU GMP approval from GREECE
  • Concord Biotech Limited receives EUGMP certificate for Dholka facility
  • Indoco's Baddi facility - Unit I receives GMP certification from EU Health Authority
  • Indoco's Baddi facility receives EUGMP certification from Health Authority of Germany
  • Kwality Pharmaceuticals Himachal Pradesh Facility received EU GMP Approval
  • EDQM grants EU-GMP for Lote API facility of Supriya Lifescience Limited
  • Biocon Biologics Receives EU GMP Certification for Its New Biologics Manufacturing Facility in Bengaluru
  • Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation
  • Windlas Biotech Limited receives EU-GMP certificate
  • Windlas Biotech concludes EU GMP Inspection, receives 0 critical observations

Latest Post

  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025